Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.5M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
44.1M
-
Shares change
-
+293K
-
Total reported value, excl. options
-
$1.96B
-
Value change
-
+$16.5M
-
Put/Call ratio
-
0.82
-
Number of buys
-
91
-
Number of sells
-
-100
-
Price
-
$44.38
Significant Holders of AtriCure, Inc. - Common Stock (ATRC) as of Q4 2022
234 filings reported holding ATRC - AtriCure, Inc. - Common Stock as of Q4 2022.
AtriCure, Inc. - Common Stock (ATRC) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.1M shares
of 49.5M outstanding shares and own 89.13% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.39M shares), BlackRock Inc. (3.74M shares), ALLIANCEBERNSTEIN L.P. (3.57M shares), Invesco Ltd. (3.37M shares), Champlain Investment Partners, LLC (1.94M shares), FRED ALGER MANAGEMENT, LLC (1.76M shares), WELLINGTON MANAGEMENT GROUP LLP (1.61M shares), First Light Asset Management, LLC (1.45M shares), MACQUARIE GROUP LTD (1.38M shares), and T. Rowe Price Investment Management, Inc. (1.2M shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.